44 related articles for article (PubMed ID: 33259726)
1. (175)Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals.
Safarzadeh L
Indian J Nucl Med; 2014 Jul; 29(3):135-9. PubMed ID: 25210277
[TBL] [Abstract][Full Text] [Related]
2. Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone pain.
Arani SS; Ghasemi S; Samani AB; Zafarghandi MS
Electron Physician; 2015; 7(1):977-84. PubMed ID: 26052408
[TBL] [Abstract][Full Text] [Related]
3. FAPI PET/CT: Will It End the Hegemony of
Hicks RJ; Roselt PJ; Kallur KG; Tothill RW; Mileshkin L
J Nucl Med; 2021 Mar; 62(3):296-302. PubMed ID: 33277397
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177-labeled Prostate-specific Membrane Antigen-targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer.
Sadaghiani MS; Sheikhbahaei S; Werner RA; Pienta KJ; Pomper MG; Solnes LB; Gorin MA; Wang NY; Rowe SP
Eur Urol; 2021 Jul; 80(1):82-94. PubMed ID: 33840558
[TBL] [Abstract][Full Text] [Related]
5. Current clinical application of lutetium‑177 in solid tumors (Review).
Niu T; Fan M; Lin B; Gao F; Tan B; Du X
Exp Ther Med; 2024 May; 27(5):225. PubMed ID: 38596660
[TBL] [Abstract][Full Text] [Related]
6. Clinical Advances and Perspectives in Targeted Radionuclide Therapy.
Lepareur N; Ramée B; Mougin-Degraef M; Bourgeois M
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376181
[TBL] [Abstract][Full Text] [Related]
7. Theragnostic Radionuclide Pairs for Prostate Cancer Management:
Chhabra A; Thakur ML
Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359312
[TBL] [Abstract][Full Text] [Related]
8. A review of advances in the last decade on targeted cancer therapy using
Chakravarty R; Chakraborty S
Am J Nucl Med Mol Imaging; 2021; 11(6):443-475. PubMed ID: 35003885
[TBL] [Abstract][Full Text] [Related]
9. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
[TBL] [Abstract][Full Text] [Related]
10. 153Sm-EDTMP for bone pain palliation in skeletal metastases.
Maini CL; Bergomi S; Romano L; Sciuto R
Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S171-8. PubMed ID: 15127241
[TBL] [Abstract][Full Text] [Related]
11.
Askari E; Harsini S; Vahidfar N; Divband G; Sadeghi R
Cancer Biother Radiopharm; 2021 Jun; 36(5):383-390. PubMed ID: 33259726
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
Yuan J; Liu C; Liu X; Wang Y; Kuai D; Zhang G; Zaknun JJ
Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
[TBL] [Abstract][Full Text] [Related]
13. Clinical Efficacy and Safety Comparison of 177Lu-EDTMP with 153Sm-EDTMP on an Equidose Basis in Patients with Painful Skeletal Metastases.
Thapa P; Nikam D; Das T; Sonawane G; Agarwal JP; Basu S
J Nucl Med; 2015 Oct; 56(10):1513-9. PubMed ID: 26315829
[TBL] [Abstract][Full Text] [Related]
14. ¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases.
Shinto AS; Shibu D; Kamaleshwaran KK; Das T; Chakraborty S; Banerjee S; Thirumalaisamy P; Das P; Veersekar G
J Nucl Med Technol; 2014 Mar; 42(1):55-61. PubMed ID: 24503346
[TBL] [Abstract][Full Text] [Related]
15. (177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study.
Agarwal KK; Singla S; Arora G; Bal C
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):79-88. PubMed ID: 25070686
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]